Keron Lifesciences Private Limited

Keron Lifesciences Private Limited - pharma in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
CIN U24297UR2012PTC000295 Incorporated 19 June 2012 ROC Uttarakhand HQ Dehradun, Uttarakhand, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹2.21 Cr
▲ 6% YoY
Net loss · FY 2025
₹1.81 Cr
Net margin -81.6%
EBITDA · FY 2025
-₹1.06 Cr
EBITDA margin -47.7%
Authorised capital
₹28 Cr
Registered with MCA
Paid-up capital
₹20.6 Cr
Issued & subscribed
Satisfied charges
₹1.75 Cr
No open charges
Company age
14 yrs
Est. 2012
Employees · EPFO
41
Provident fund records

About Keron Lifesciences Private Limited

Data last updated:

Keron Lifesciences Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 June 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24297UR2012PTC000295. Its GSTIN is 05AAECK8314N1ZA (Uttarakhand). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹28 Cr and a paid-up capital of ₹20.6 Cr. It is led by directors including Ralph Leslie Dsouza and Ghazi Yousef Abdullateef Alabdulrazzaq.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 5 Sara Industrial Estate Rampur, Dehradun, Uttarakhand, India – 248197.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.21 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹1.81 Cr (net margin -81.6%) and EBITDA of -₹1.06 Cr (EBITDA margin -47.7%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years.

The company has about 41 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹1.75 Cr on record. Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.

Keron Lifesciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0017099). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keronlifesciences.com.

Company details

CIN U24297UR2012PTC000295
Registration Number 000295
Incorporation Date 19 June 2012
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0017099

Recognitions & Rankings of Keron Lifesciences

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UK-05-0017099

Contact details

Keron Lifesciences Private Limited's registered office is in Dehradun, Uttarakhand. Its website is keronlifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    D – 5 Sara Industrial Estate Rampur, Dehradun, Uttarakhand, India – 248197
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Keron Lifesciences Private Limited, buy the company report.

Comprehensive company report
Keron Lifesciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Keron Lifesciences is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Keron Lifesciences Private Limited, buy the company report.

Financials of Keron Lifesciences Private Limited

FY 2025 filings available

Keron Lifesciences Private Limited reported revenue of ₹2.21 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹2.21 Cr ▲ 6%
Net loss · FY 2025
₹1.81 Cr margin -81.6%
EBITDA · FY 2025
-₹1.06 Cr margin -47.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 25%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 25%
5 years · compounded
▲ 12%

Revenue rose 6% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 25%. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.06 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.81 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-47.7%
Net Profit Margin-81.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Keron Lifesciences Private Limited, buy the company report.

Board of directors of Keron Lifesciences Private Limited

Keron Lifesciences has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ralph Leslie DsouzaDirector25 May 20215 Years 4 MonthsCurrent
Ghazi Yousef Abdullateef AlabdulrazzaqDirector28 Feb 201610 Years 7 MonthsCurrent
Shailesh Kumar Narmedeshwar Dutt MishraDirector28 Feb 201610 Years 7 MonthsCurrent
Abdulmohsin Yousef Abdul Lateef AlabdulrazzaqDirector28 Feb 201610 Years 7 MonthsCurrent
Manoj Dhankumar JainDirector08 Dec 20223 Years 10 MonthsCurrent

Auditor

Keron Lifesciences Private Limited is audited by BPP & COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
BPP & COMPANYFY 2023023361N

Shareholding

The shareholding of Keron Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Keron Lifesciences Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.75 Cr
Breakdown by lending institutions
United Bank of India₹1.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
27 Jul 201310446587United Bank of India₹1.75 CrSatisfied

To see the full charge records of Keron Lifesciences Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

Keron Lifesciences Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
an individual supplier

To see the full MSME payment records of Keron Lifesciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Keron Lifesciences Private Limited has a workforce of 41 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
41
Active EPFO establishments
1
Employee growth
28.12%

GST

Keron Lifesciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
05AAECK8314N1ZAUttarakhandActive01 Jul 2017
09AAECK8314N1Z2Uttar PradeshActive22 Aug 2019

To see the full GST registrations and return filing status of Keron Lifesciences Private Limited, buy the company report.

Recent activity

Keron Lifesciences Private Limited has 19 board changes on record since 2012: 12 appointments and 7 cessations. The latest: Manoj Dhankumar Jain was appointed as Director on 08 Dec 2022.

AGM
Keron Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Keron Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand.
Appointed
Manoj Dhankumar Jain was appointed as Director.
Ceased
Prashant Tiwari ceased to be Director.
Ceased
Piyush Kant Sharma ceased to be Director.
Appointed
Prashant Tiwari was appointed as Director.
Appointed
Ralph Leslie Dsouza was appointed as Director.
Ceased
Lawrance Dsouza ceased to be Director.
Ceased
Mukesh Mrinal ceased to be Director.
Ceased
Arvind Kumar Jha ceased to be Director.
Appointed
Piyush Kant Sharma was appointed as Director.
Appointed

12 earlier events are in the company report.

Frequently asked questions

Keron Lifesciences is an active private limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 June 2012 (14+ years old) and is registered under CIN U24297UR2012PTC000295.

The latest financial statements of Keron Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Keron Lifesciences is 05AAECK8314N1ZA, registered in Uttarakhand. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAECK8314N1Z2 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Keron Lifesciences is U24297UR2012PTC000295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Keron Lifesciences has 4 court cases on record: 4 filed by the company. 3 are pending.

Keron Lifesciences was incorporated on 19 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttarakhand.

Manoj Dhankumar Jain was appointed as Director on 08 Dec 2022. Prashant Tiwari ceased to be Director on 22 Mar 2022. Piyush Kant Sharma ceased to be Director on 24 Oct 2021. Keron Lifesciences has 19 board changes on record in total.

Yes, Keron Lifesciences is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0017099).

Keron Lifesciences has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.

Keron Lifesciences can be reached through the website keronlifesciences.com. Its registered office is in Dehradun, Uttarakhand, India.